Conclusion
cardiometabolic disease
Medication nonadherence and DDI are preventable sources of patient harm and poor health outcomes in chronic cardiometabolic disease management. Improved diagnosis using a reliable and convenient test potentially improves patient quality of life, medication safety, clinical outcomes, and cost-efficient health delivery.